ACVRL1 and hereditary hemorrhagic telangiectasia: Patients with HHT harbor loss-of-function mutations in genes encoding activin receptor-like kinase 1 (ALK1) (1), its coreceptor ENDOGLIN (2), or the downstream transcription factor SMAD4 (3).